Sep 17, 2020
Postman uses trash and old items to create unique folk art exhibit in East End
This news has been received from: abc7ny.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
HOUSTON, Texas -- Back in 1956, postman Jeff McKissack started to create The Orange Show in Houston, Texas.
The idea behind the project was to honor his favorite fruit - the orange! He believed the magical citrus promoted longevity.
For more than 20 years, McKissack would search around the Houston area for anything to use in his project including tiles, old wagon wheels, tossed building materials from construction sites, metal fencing, and items collected from antique shops.
He used anything and everything to convert a piece of property across the street from his home, into a historical piece of folk art that's well known to Houstonians today.
The Orange Show's structure is starting to feel the effects of extreme weather conditions in Houston, so they're hoping people can contribute to help persevere the property for future generations to enjoy.
News Source: abc7ny.com
FDA greenlights point-of-care coronavirus antibody test that uses blood samples
The Food and Drug Administration (FDA) granted Assure Tech emergency use authorization for a point-of-care test capable of detecting past COVID-19 infections through blood samples.
In July, the Assure COVID-19 IgG/IgM Rapid Test Device was first authorized for emergency use by some labs to identify individuals with antibodies to SARS-CoV-2, indicating a recent or prior infection to COVID-19.
LARGE ANTIBODY STUDY OFFERS HOPE FOR VIRUS VACCINE EFFORTS
As of Wednesday, the test is now authorized for point-of-care use using a blood sample from the fingertip. This means it can be tested in settings like "doctor’s offices, hospitals, urgent care centers and emergency rooms rather than having to be sent to a central lab for testing," the FDA announced.
FDA Commissioner Stephen Hahn said the point-of-care serology tests "will enable more timely and convenient results" for people who want to know if they have previously been infected with the virus.
SECOND ABBOTT CORONAVIRUS ANTIBODY TEST GETS EMERGENCY USE AUTHORIZATION
Until Wednesday, serology test samples were generally evaluated in a central lab, which Hahn noted can be "time consuming and use additional resources to transport samples and run the test."
With more point-of-care serology tests authorized, Hahn says health care workers will be able to better conserve those resources. It may also "help reduce processing time for other types of COVID-19 tests, as less time is spent on serology tests," he added.
Since the onset of the pandemic, nearly 50 serology tests have been granted emergency use authorization.
However, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity, the FDA says. The agency said patients should not consider themselves "immune, or have any level of immunity, from the virus" based on the results.
CLICK HERE TO GET THE FOX NEWS APP